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Abstract
Objective—To assess how healthcare professionals caring for patients in intensive care units 
(ICUs) understand and use antimicrobial susceptibility testing (AST) for multidrug-resistant gram-
negative bacilli (MDR-GNB).
Design—A knowledge, attitude and practice survey assessed ICU clinicians knowledge of 
antimicrobial resistance, confidence interpreting susceptibility testing, and beliefs regarding the 
impact of susceptibility testing on patient outcomes.
Setting—16 ICUs affiliated with New York-Presbyterian Hospital.
Participants—Attending physicians and subspecialty residents with primary clinical 
responsibilities in adult or pediatric ICUs and infectious diseases (ID) subspecialists and clinical 
pharmacists.
Methods—Participants completed an anonymous electronic survey. Responses included 4-level 
Likert scales dichotomized for analysis. Multivariate analyses were performed using Generalized 
Estimating Equations logistic regression to account for correlation of respondents from the same 
ICU.
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Results—The response rate was 51% (178/349 eligible participants) of whom 120 (67%) were 
ICU physicians. Those caring for adult patients were more knowledgeable about antimicrobial 
activity and more familiar with MDR-GNB infections. Only 33% and 12% of ICU physicians 
were familiar with standardized and specialized AST methods, respectively, but >95% believed 
AST improved patient outcomes. When adjusted for demographic and healthcare provider 
characteristics, those familiar with treatment of MDR-GNB bloodstream infections, those aware of 
resistance mechanisms, and those aware of AST methods were more confident they could interpret 
AST and/or request additional in vitro testing.
Conclusions—Our study uncovered knowledge gaps and educational needs that could serve as 
the foundation for future interventions. Familiarity with MDR-GNB increased overall knowledge 
and familiarity with AST increased confidence interpreting these results.
INTRODUCTION
Infections caused by multidrug-resistant gram-negative bacilli (MDR-GNB) such as 
Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter species have 
increased, particularly in intensive care units (ICUs), due to numerous factors including 
antimicrobial selective pressure, horizontal acquisition of genes that encode for 
antimicrobial resistance, contamination of the healthcare environment with MDR-GNB with 
subsequent transmission to patients, and patient-to-patient transmission via the hands of 
healthcare workers. 1–4 Infections caused by MDR-GNB are associated with increased 
morbidity, mortality, length of stay, and healthcare costs.5–9 Furthermore, successful 
treatment of MDR-GNB infections may be hampered by limited therapeutic options as well 
as the knowledge, attitudes, and practices of healthcare providers regarding optimal 
management of MDR-GNB infections.
Little is known about how healthcare professionals caring for patients in the ICU understand 
and use the results of antimicrobial susceptibility testing for MDR-GNB. The aims of this 
study were to assess the knowledge, attitudes, and practices of ICU healthcare professionals 
regarding the following: antimicrobial resistance, in vitro susceptibility testing for MDR-
GNB, relevant transmission precautions, and the activity of specific antimicrobial agents. In 
doing so, we sought to identify knowledge gaps and educational opportunities that could 
ultimately be used to improve care for ICU patients infected with MDR-GNB.
MATERIALS AND METHODS
Study Sites
Eligible respondents worked in the adult and pediatric ICUs of New York-Presbyterian 
Hospital (NYP) which is affiliated with Weill Cornell (WC) Medical College and Columbia 
University Medical Center (CUMC). In all, NYP has 16 ICUs with 214 beds for adults, 170 
beds for children and neonates, and approximately 14,814 annual admissions. Clinical 
microbiology laboratories are located on site at both the WC campus and the CUMC 
campus. The laboratories report antimicrobial susceptibility data in the electronic medical 
record as both minimal inhibitory concentrations (µg/ml) and their interpretation based on 
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relevant breakpoints (susceptible, intermediate, or resistant). The Institutional Review 
Boards of WC and CUMC approved this study with a waiver of written informed consent.
Study Design, Participants and Sites
From February 2009 to June 2009, eligible participants were asked to complete an 
anonymous, self-administered web-based survey that required 10–15 minutes to complete. 
Eligible healthcare professionals included: attending physicians and subspecialty residents 
with primary clinical responsibilities in ICUs caring for adult (e.g., medical, surgical, burn 
ICUs) or pediatric (e.g., pediatric, neonatal ICUs) patients as well as ID subspecialists and 
clinical pharmacists who consulted in these ICUs. Eligible participants were invited to 
participate by email and three reminder emails were sent. Participants received a $20 
Starbucks gift card for completing the survey and could enter a $500 raffle intended for use 
to attend a professional meeting.
Knowledge, Attitudes, and Practices Survey
The knowledge, attitudes, and practices survey was developed by an interdisciplinary team 
of ID physicians, hospital epidemiologists, and a clinical pharmacist and used the paradigm 
developed by Cabana and colleagues to assess knowledge, attitude and practice barriers to 
adherence to treatment guidelines experienced by clinicians. 10–14 The survey assessed 
knowledge, awareness, and familiarity with treatment of infections caused by MDR-GNB 
and with relevant infection control policies (eTable 1). The survey assessed respondents’ 
perceptions of the usefulness and impact of in vitro susceptibility testing on patient 
outcomes (outcome expectancy), respondents’ confidence using susceptibility data (self-
efficacy), and respondents’ use of other clinical resources, e.g., ID consultations and 
electronic antimicrobial prescribing resources. The survey items incorporated forced choice 
format and Likert scales.
Statistical Analysis
Responses to the Likert scales were dichotomized as shown in eTable 1. For example, 
“strongly disagree and disagree” were combined. Mantel Haenszel chi square tests were 
used to examine the association between the independent variables (e. g., type of healthcare 
professional) and dependent variables (i.e., knowledge, attitudes, and practices). As the 
responses of the 8 clinical pharmacists were very similar to those of the ID physicians, 
responses were combined as “ID healthcare professionals”.
To further improve our understanding of factors that may influence the use of susceptibility 
testing, we assessed the impact of familiarity with MDR-GNB infections and awareness of 
susceptibility testing methods on respondents’ confidence interpreting susceptibility results 
or use of specialized susceptibility testing such as Etests® (bioMérieux Inc., Durham, NC). 
The multivariate models included age, gender, work site, type of healthcare professional, 
primary patient population served (pediatric vs. adult), and training status as independent 
variables. Multivariate analyses were performed using Generalized Estimating Equations 
logistic regression15 to account for the correlation of respondents from the same ICU; 95% 
confidence intervals and p-values were adjusted for the possible increase in false positives 
due to multiple comparisons by setting the false discovery rate to be no more than 5%.
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RESULTS
Respondent Characteristics
Of 349 eligible participants, 178 (51%) completed the survey and their characteristics are 
shown in Table 1. The response rate by adult and pediatric ICU physicians was similar at 
CUMC and WC (data not shown). However, compared with eligible participants working 
with adult populations, a larger proportion of pediatric healthcare providers responded to the 
survey (79/239, 33% vs. 76/110, 69%; p<0.05). The characteristics of respondents from WC 
and CUMC were generally similar, but a larger proportion of respondents from CUMC were 
pediatric healthcare professionals than respondents from WC (50/90, 56% vs. 23/61, 38%; 
p<0.05). Twenty nine (24%) respondents worked in more than one ICU.
Respondents’ Knowledge, Attitude, and Practices
The majority of respondents agreed that infections caused by MDR-GNB were a serious 
problem in ICUs in the United States (97%) as well as at NYP (96%).
Agreement with Potential Strategies to Reduce MDR-GNB—The majority of 
respondents (96%) agreed that limiting broad spectrum antimicrobial agents could decrease 
resistance. More ID healthcare professionals (93%) than ICU healthcare professionals (74%) 
agreed that implementing Contact Isolation for patients colonized/infected with MDR-GNB 
could decrease antimicrobial resistance (p< 0.05). However, only 67% of ID and 56% of 
ICU healthcare professionals were aware of the NYP definition used to initiate Contact 
Isolation which had been in place since 2006. At the time of the survey, MDR-GNB were 
defined as strains susceptible to < 1 tested antimicrobial agent (excluding polymyxin or 
tigecycline) or those that were resistant to carbapenem agents or expressed extended 
spectrum β-lactamases.
Familiarity with MDR-GNB Infections—Compared with ID healthcare professionals, 
ICU physicians were less likely to be “extremely/ very familiar” with treatment of 
bloodstream infections (91% vs. 55%, respectively, p<0.05), pneumonia (86% vs. 43%, 
p<0.05), and urinary tract infections (84% vs. 50%, p<0.05) caused by MDR-GNB. Adult 
and pediatric ICU physicians were similarly familiar with treatment of bloodstream 
infections (56% vs. 52%) and urinary tract infections (56% vs. 45%) caused by MDR-GNB, 
but adult ICU physicians were more familiar with treatment of pneumonia caused by MDR-
GNB (60% vs. 29%, p<0.05).
Knowledge of Antimicrobial Agents—Respondents’ knowledge of the activity of 
antimicrobial agents is shown in Table 2. ID healthcare professionals had more correct 
answers than ICU physicians and the knowledge of ICU attendings and fellows was similar 
(data not shown). ICU physicians working with adult patients were more likely to know that 
tigecycline was inappropriate for pneumonia caused by Pseudomonas aeruginosa and that 
quinolone agents were inappropriate for treatment of carbapenem-resistant Klebsiella spp. 
Almost all (98%) ID healthcare professionals were aware of the resistance mechanisms 
expressed by MDR-GNB while only 50% of ICU physicians reported they were aware of 
these mechanisms (p<0.05).
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Use of Susceptibility Testing—Most ID healthcare professionals (86%) were aware of 
both the standard, commercial antimicrobial susceptibility testing methods (i.e., 
MicroScan® [Siemens Healthcare Diagnostics Inc., Tarrytown, NY] and Vitek® assays 
[bioMérieux Inc., Durham, NC]) and specialized antimicrobial susceptibility testing 
methods (i.e., Etest assays for susceptibility to tigecycline and polymyxin B, and 
checkerboard synergy testing for selected agents) used at NYP. Far fewer ICU physicians 
were aware of either standard (33%) or specialized assays (12%). Consistent with these 
observations, when compared with ID healthcare professionals, ICU healthcare 
professionals rarely requested additional susceptibility testing (57% vs. 23%, respectively, 
p<0.05). A comparable proportion of ID and ICU healthcare professionals agreed that 
susceptibility testing was useful for managing MDR-GNB infections (91% and 95%, 
respectively), and reported that they “often or always” modified treatment based on 
susceptibility testing (93%). However, when compared with ID healthcare professionals, 
fewer ICU physicians were aware that commercial assays for susceptibility testing could be 
inaccurate, i.e., provide false negative or false positive results, (90% vs. 57%, respectively, 
p< 0.05).
Most ID healthcare professionals had confidence (self-efficacy) in their ability to use local 
resistance patterns, interpret susceptibility testing, and review the literature to determine 
treatment strategies (Table 3). In contrast, most ICU physicians lacked confidence they 
could perform these tasks, although those caring for adult patients were somewhat more 
confident. The confidence of ICU attending physicians vs. ICU fellows was similar (data not 
shown).
Respondents’ Perceptions of External Prescribing Resources—Nearly all 
respondents believed that in vitro susceptibility testing could improve outcomes for patients 
with MDR-GNB infections (Table 4). Similarly, most believed that consults from ID 
healthcare professionals could improve patient outcomes, although compared with adult ICU 
physicians, pediatric ICU physicians were more likely to consider consults useful and to 
request them (p< 0.05).
Both groups of healthcare professionals considered the NYP web-based resources to be the 
most important resource to guide antimicrobial prescribing for treatment of MDR-GNB, 
although ID healthcare professionals were more likely to consider the literature important 
(Table 4). Compared with ICU attending physicians, ICU fellows were significantly more 
likely to consider literature searches, formal lectures, and electronic references important 
resources for managing MDR-GNB infections (data not shown, p< 0.05).
Factors Influencing Respondents’ Confidence Interpreting Susceptibility Tests
When adjusted for demographic and healthcare provider characteristics, knowledge of 
MDR-GNB, of resistance mechanisms, and of antimicrobial susceptibility testing impacted 
respondents’ confidence and practices (Table 5). For example, those familiar with treatment 
of bloodstream infections caused by MDR-GNB were more confident they could interpret 
both standard and specialized susceptibility tests. Those aware of resistance mechanisms 
were also more confident they could interpret susceptibility tests as well as request 
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specialized testing. In contrast, awareness of standardized or specialized susceptibility tests 
did not impact respondents’ confidence they could interpret specialized test results. 
Furthermore, familiarity with treatment of bloodstream infections caused by MDR-GNB did 
not increase respondents’ requests for specialized testing.
DISCUSSION
Antimicrobial prescribing practices are known to be influenced by sociodemographic 
characteristics, training, specialty, knowledge, attitudes, and judgment.16 Studies have 
shown that selection of antimicrobials is more likely to reflect the prescriber’s assessment of 
efficacy, ease of use, previous experience, toxicity, and cost considerations than the impact 
of selection for resistance.17,18 In the outpatient setting, patient demands for antimicrobials 
are frequently cited as an important influence on prescribing practices.17 However, in the 
inpatient setting, clinicians are largely free of such demands. Thus, improving prescribing in 
the acute care setting can preferentially focus on understanding prescribers’ knowledge, 
attitudes, and practices to identify potential barriers to optimal care.19 We sought to address 
these complex issues among healthcare professionals caring for adult and pediatric patients 
hospitalized in ICUs and focused on treatment of infections caused by MDR-GNB, 
including respondents’ confidence using antimicrobial susceptibility data and their 
perceptions of the impact of antimicrobial susceptibility testing on patient outcomes. To our 
knowledge, only one previous study has been conducted among a similar group of 
Australian providers which found that 89% of ID and ICU healthcare providers believed that 
results of susceptibility testing were an important influence on their antimicrobial 
prescribing.20
Several surveys about antimicrobial resistance have been conducted with different types of 
healthcare workers, including medical students, residents, and attending physicians (Table 
6).21–25 These previous studies have found that 87% to 97% of respondents viewed 
resistance as a national problem while fewer (55% to 93%) viewed resistance as a local 
problem.17,19,21–24 In contrast, we found that the vast majority of respondents at our 
institution agreed that MDR-GNB infections were a serious problem in ICUs both in the 
U.S. and at our medical center. Both ID and ICU healthcare professionals shared this 
attitude. These findings suggest that providers at our medical center were knowledgeable 
about this issue as MDR-GNBs, including strains that express carbapenemases, have been a 
major problem in New York City hospitals for over a decade.26,27 Previous studies have 
found that respondents underestimated the prevalence of resistance, particularly at their own 
institution.21,24,25 As noted in previous studies and our study, most healthcare providers 
believed that excess use of antimicrobials was a cause of resistance,24,25 but fewer believed 
that antimicrobials were overused in the hospitals in which they worked.22,23
Our survey uncovered a substantial knowledge gap which may delay appropriate 
implementation of transmission precautions and thus facilitate transmission of multidrug-
resistant organisms.4 Among ICU providers, only 74% agreed that implementing Contact 
Isolation for patients harboring MDR-GNB could decrease resistance and even fewer 
respondents were aware of the MDR-GNB definition used to initiate such precautions.
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ICU healthcare professionals working with adult populations were more knowledgeable 
about the activity of antimicrobial agents than those working with pediatric populations. 
This may reflect the relative infrequency with which infections caused by MDR-GNB are 
seen in pediatric populations; from 2007–2009, the prevalence of the most common MDR-
GNB in the pediatric ICUs was 2.6% while in adult ICUs was 6.6% (unpublished 
observation, E Yoko Furuya). In addition, these findings suggest that clinical pharmacists 
play an important role in educating physicians in ICU settings as ICU providers working 
with adult populations had more contact with clinical pharmacists than those providers 
working with pediatric populations. Nonetheless, many ICU healthcare professionals lacked 
confidence they could use local resistance patterns to guide empiric therapy or interpret 
susceptibility testing results. However, those respondents who were more familiar with 
treatment of bloodstream infections caused by MDR-GNB, with resistance mechanisms, and 
with susceptibility testing methods were more confident they could interpret and request 
susceptibility testing. Of note, the vast majority of respondents perceived that such results 
would improve patient outcomes.
These observations suggest possible educational strategies. Case vignettes of MDR-GNB 
infections could be used to supplement the lack of knowledge and familiarity experienced by 
some providers.28 To be effective, the educational strategy should address general principles 
such as mechanisms of resistance expressed by MDR-GNB, pharmacokinetic principles for 
different types of infections, and methods of susceptibility testing. Content should also 
include locally relevant information such as the institutional antibiogram, pathogen 
distribution, relevant empiric therapy and targeted therapy, and interpretation of relevant 
microbiology reports. As ICU fellows considered literature searches, formal lectures, and 
electronic references as important resources for managing MDR-GNB infections, mastering 
these strategies could be integrated into educational efforts. Previous studies have also 
explored the educational needs of healthcare professionals regarding antimicrobial use and 
resistance (Table 6).21–25 Many respondents desired educational sessions on antimicrobial 
use, prescribing guidelines, and feedback on their prescribing practices.22,23,25 As we and 
others have noted, interactive education appears to be generally preferred to didactic 
sessions or handouts as reflected in providers’ desire for feedback or preference for the 
advice of local experts and local resources.21,25 As further evidence of the effectiveness of 
prescriber audit and feedback, this evidence-based strategy is recommended to improve 
antimicrobial stewardship.29
This study had several limitations. While this multicenter study was conducted on 4 
different campuses, all the ICUs are part of a single academic medical center with both 
infectious disease physicians and clinical pharmacists with ICU and ID expertise. Thus our 
study may lack generalizability. The components of the survey reflected the institutional 
biases of the interdisciplinary team that created the survey. Despite reminders and 
incentives, only 51% of eligible respondents completed the survey. We could not compare 
the responses of medical ICU physicians with those of surgical ICU physicians as many of 
the respondents provided service in both types of ICUs. Our study may have lacked some 
internal validity as adult and pediatric providers may have experienced different patterns of 
resistance, different access to clinical pharmacists, and different patterns of usage of agents 
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such as tigecycline. Finally, self-reported adherence to practices may not reflect true 
practices.
CONCLUSION
This study uncovered knowledge gaps and educational needs that could serve as the 
foundation for future interventions to improve antimicrobial treatment and use of 
susceptibility testing for MDR-GNB. Familiarity with infections caused by MDR-GNB 
increased overall knowledge and familiarity with susceptibility testing methods and 
increased confidence interpreting these results. Our findings and the findings of others 
suggest that an interactive educational strategy should include case vignettes, the input of 
local experts, particularly to interpret specialized susceptibility testing, and prescriber 
feedback.
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Table 1
Characteristics of Respondents (N=178)
Characteristics Respondents (n, %)
Demographic
Age (years) ≤ 30 23 (13)
31–40 80 (45)
≥ 41 58 (32)
Unknown 17 (10)
Sex Female 83 (47)
Male 76 (43)
Unknown 19 (10)
Race Black 2 (1)
White 113 (64)
Asian 28 (16)
Other 6 (3)
Unknown 29 (16)
Ethnicity (Hispanic) 8 (1)
Type of Healthcare Professional
Intensive Care Unit Physiciana 120 (67)
Infectious Diseases Physicianb 35 (20)
Clinical Pharmacistc 8 (5)
Unknown 15 (8)
Primary Patient Population Served
Pediatric 76 (43)
Adult 79 (44)
Unknown 23 (13)
Work Site
Weill Cornell Medical College 61 (34)d
Columbia University Medical Center 90 (51)e
Both 4 (2) f
Unknown 23 (13)
a74 attending physicians and 46 fellows
b27 attending physicians and 8 fellows
c2 clinical pharmacists worked with pediatric populations
d44% of 138 eligible participants
e43% of 211 eligible participants
f7% of 349 eligible participants work at both sites
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Table 2
Healthcare Professionals’ Knowledge of the Activity of Antimicrobial Agents
Questions
(Correct answer)
ID
HCP
n=43
ICU
HCP
n=120
Adult
ICU
n= 55
Pediatric
ICU
n=65
Participants with Correct Response (%)
Carbapenem agents are ineffective for GNB
expressing extended spectrum β-lactamases.
(False)
98a 64 64 65
Tigecycline is an option for hospital-associated
pneumonia caused by MDR- Pseudomonas aeruginosa
(False)
83a 25 36b 15
Carbapenem-resistant Klebsiella spp. are usually
susceptible to quinolone agents.
(False)
86a 37 58b 19
Quinolone agents exhibit concentration-
dependent killing.
(True)
60a 28 33 25
Correct answers per respondent (mean) 3.3 1.5 1.9 1.2
Abbreviations used in Table: ID, infectious diseases; HCP, healthcare professional; ICU, intensive care unit; MDR, multidrug-resistant; GNB, 
gram-negative bacilli.
a
p<0.05 when comparing responses of ID HCP vs. ICU HCPs.
b
p<0.05 when comparing responses of adult vs. pediatric ICU HCPs.
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Table 3
Healthcare Professionals Confidence (Self-Efficacy) in Their Ability to Use Antimicrobial Susceptibility 
Testing
Questions
ID
HCP
n=43
ICU
HCP
n=120
Adult
ICU
n= 55
Pediatric
ICU
n=65
Participants ‘very/extremely confident’ (%)
Use antimicrobial resistance patterns in the
ICU to guide empiric antibiotic therapy.
67 46 56b 37
Interpret standard, commercial antimicrobial
susceptibility testing results for MDR-GNB.
65 41 47 35
Interpret additional, specialized antimicrobial
susceptibility testing results for MDR-GNB.
61a 18 28b 9
Use literature to determine optimal treatment
strategies for MDR-GNB infections.
63a 33 31 34
Abbreviations used in Table: ID, infectious diseases; HCP, health care professional; ICU, intensive care unit; MDR, multidrug-resistant; GNB, 
gram-negative bacilli.
a
p<0.05 when comparing responses of ID vs. ICU HCPs.
b
p<0.05 when comparing responses of adult vs. pediatric ICU HCPs.
Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2015 July 07.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Zhou et al. Page 13
Table 4
Healthcare Professionals Perceptions of Importance of External Factors on Patient Outcomes and Management 
of MDR-GNB Infections
Importance of Factors
ID
HCP
n=43
ICU
HCP
n=120
Adult
ICU
n= 55
Pediatric
ICU
n=65
Responding ‘moderately/ extremely
important’ (%)
To improve patient outcomes
• Susceptibility testing results 100 95 96 94
• Pre-approval for restricted antibiotics 83 83 78 88
• Infectious diseases consult N/A 92 83b 99
• Clinical pharmacist consults N/A 76 80 72
To guide antimicrobial prescribing
• Literature searches 91a 71 69 72
• Formal lectures 86 79 75 83
• Pocket guides or PDA-based references 57 66 75b 57
• NYP web-based resources 95 90 93 88
• Other web-based resources available
through NYPH (e.g., Up-to-date)
80 83 83 83
• Outside web-based resources (e.g.,
Johns Hopkins guide, MD consult)
58 64 64 64
Abbreviations used in Table: ID, infectious diseases; HCP, health care professional; ICU, intensive care unit; MDR, multidrug-resistant; GNB, 
gram-negative bacilli; N/A, not applicable; NYP, NewYork-Presbyterian Hospital.
a
p<0.05 when comparing responses of ID vs. ICU HCPs.
b
p<0.05 when comparing responses of adult vs. pediatric ICU HCPs.
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Table 5
Impact of Knowledge of MDR-GNB Infections, Resistance Mechanisms, and Susceptibility Testing on 
Interpretation and Use of Specialized Susceptibility Testing
Knowledge variables
Confident
interpreting
standard AST
Confident
interpreting
specialized AST
Request
specialized AST
AOR (CI95)
Familiarity with BSI
caused by MDR-GNB
1.32 (1.05–1.67) 1.23 (1.08–1.40) NS
Awareness of MDR-GNB
resistance mechanisms
1.49 (1.33–1.67) 1.27 (1.20–1.35) 1.23 (1.03–1.48)
Awareness of standard
AST
1.39 (1.25–1.55) NS 1.36 (1.14–1.63)
Awareness of specialized
AST
1.29 (1.10–1.52) NS 1.69 (1.29–2.22)
Abbreviations used in Table: BSI, blood stream infection; MDR-GNB, multidrug-resistant gram-negative bacilli; AST, antimicrobial susceptibility 
testing; AOR, adjusted odds ratio; CI, confidence interval; NS, not significant;
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Table 6
Surveys of Healthcare Professionals’ Knowledge, Beliefs, and Educational Needs regarding Antimicrobial 
Treatment and Resistance in Acute Care Settings
Country Respondents Major findings
Response
rate
n/N (%)
Knowledge Attitudes/ Beliefs Educational Needs
France &
Scotland25
Residents
139/190
(73%)
Underestimated
national
prevalence of
resistance
Too many antimicrobials used
(including broad spectrum agents)
and sub-therapeutic antimicrobials
important causes of resistance
Prescribing guidelines
Educational sessions on antimicrobial
selection
Advice from infectious diseases
specialists
USA 23 Medical
Students
304/999
(34%)
Not reported 92% agreed hospitals face serious
problem with resistance
53% believed antimicrobials
overused in their hospital
More education about antimicrobial
use (78%)
Brazil 21 Preceptors &
medical
residents
277/369
(75%)
Underestimated
own institution’s
prevalence of
resistance
87% believed physicians
prescribed more antimicrobials
than necessary.
86% agreed physicians lack
knowledge about antimicrobial use
and resistance
Education (44%) and knowing
pathogen and susceptibility results
(30%) rated as most important
strategies to prevent resistance
USA 22 Residents
179/269
(67%)
Low (28%) overall
knowledge score
72% believed antimicrobials
overused in their hospitals
25% felt very confident using
antimicrobials optimally in ICU
More antimicrobial education (90%)
More feedback on antimicrobial
decisions (67%)
USA 24 Medicine
attendings &
residents
424/490
(87%)
Underestimated
own institution’s
prevalence of
resistance
97% believed overuse of
antimicrobials increased
resistance
60% favored antimicrobial
control
Current antibiograms
Institution-specific prescribing
guidelines
Grand rounds on antimicrobial
prescribing
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